InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Cawkwell Gail, Directeur Exécutif. Director active across 2 companies, notably Intercept Pharmaceuticals, INC.. Aggregated, 7 filings have been logged. History available since 12 May 2021. The latest transaction was disclosed on 12 February 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Cawkwell Gail
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
15,000 sharesCommon StockSEC:0001209191-23-041060:0
320 shares@ US$15.804.3% of flowCommon StockSEC:0001104659-22-023838:0
6,600 shares0Common StockSEC:0001104659-22-009553:0
2,455 shares@ US$16.2965.5% of flowCommon StockSEC:0001104659-22-000909:0
319 shares@ US$19.049.8% of flowCommon StockSEC:0001104659-21-140028:0
319 shares@ US$15.287.7% of flowCommon StockSEC:0001104659-21-105301:0
319 shares@ US$17.758.7% of flowCommon StockSEC:0001104659-21-066143:0
7 of 7 declarations
About Cawkwell Gail
Gail Cawkwell is the Executive Vice President of Medical Affairs, Safety & Pharmacovigilance at Intercept Pharmaceuticals, Inc. She is responsible for medical strategy and product safety. Her expertise is essential for ensuring compliance and safety of treatments.
